Extracellular RNA Biomarkers of Myotonic Dystrophy

Status Recruiting

Clinical Trial Summary

Current methods of measuring the response to new treatments for muscular dystrophies involve the examination of small pieces of muscle tissue called biopsies. The investigators are interested in finding less invasive methods that reduce the need for muscle biopsies. The purpose of this research is to learn about the possibility of detecting and measuring the activity and severity of muscular dystrophies by examining a urine sample and a blood sample.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Myotonic Dystrophy

Clinical Trial Details

NCT number	NCT05020002
Study type	Observational
Source	Massachusetts General Hospital
Contact	Tamkin Shahraki, MD
Phone	617-726-7506
Email	tshahraki@mgh.harvard.edu
Status	Recruiting
Phase
Start date	December 8, 2020
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04624750` - Open Label Study in Adolescents and Children With Myotonic Disorders	Phase 3
Recruiting	`NCT00082108` - Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
Recruiting	`NCT05890833` - The Risk of Falls Index for Patients With Neuromuscular Disorders
Completed	`NCT05027269` - Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients	Phase 1/Phase 2
Completed	`NCT00233519` - Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)	Phase 1/Phase 2
Completed	`NCT00167609` - Efficacy and Safety of DHEA for Myotonic Dystrophy	Phase 2/Phase 3
Recruiting	`NCT06411288` - Global Study of Del-desiran for the Treatment of DM1	Phase 3
Recruiting	`NCT04003363` - The United Kingdom National Registry for Myotonic Dystrophy
Completed	`NCT01136330` - DM1 Heart Registry - DM1 Respiratory Registry	N/A
Completed	`NCT02375087` - Sleep Breathing Disorders, a Main Trigger for Cardiac ARythmias in Type I Myotonic Dystrophy ?
Completed	`NCT01406873` - Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1	Phase 2
Completed	`NCT03959189` - Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1	Phase 1
Completed	`NCT01931644` - At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Recruiting	`NCT00127582` - RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy	Phase 3
Recruiting	`NCT02398786` - Myotonic Dystrophy Family Registry
Recruiting	`NCT05019625` - Biomarker Development for Muscular Dystrophies
Active, not recruiting	`NCT04616807` - An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders
Active, not recruiting	`NCT05479981` - Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients	Phase 2
Terminated	`NCT02315339` - European Home Mechanical Ventilation Registry
Not yet recruiting	`NCT06147414` - Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders